Cardiovascular Devices Market Size | Is Prognosticated to Reach USD
Key Prominent Players Covered in the Cardiovascular Devices Market Research Report Are B. Braun Melsungen AG (Melsungen, Germany) , Medtronic (Dublin, Ireland) , Abbott (Abbott Park, U.S.), Boston Scientific Corporation (Marlborough, U.S.) , Edwards Lifesciences Corporation (Irvine, U.S.) , Johnson & Johnson Services, Inc. (New Brunswick, U.S.) , GENERAL ELECTRIC COMPANY (GE Healthcare) (Chicago, U.S.) , LivaNova PLC (London, U.K.) , Siemens Healthcare GmbH (Erlangen, Germany) , Terumo Cardiovascular Systems Corporation (Tokyo, Japan) , Other Prominent Players
Pune, India, Sept. 06, 2021 (GLOBE NEWSWIRE) — The global cardiovascular devices market size is prognosticated to reach USD 86.27 billion by 2028 from USD 54.08 billion in 2021, exhibiting a CAGR of 6.9% during the forecast period. There are increasing cases of heart diseases such as coronary artery disease, heart failure, congenital heart disease, heart attack, cardiomyopathy, and others. It can have a tremendous impact on the market. Moreover, the increasing geriatric population and their vulnerability to various chronic diseases, especially heart diseases, are major factors propelling the growth of the market. This information is published in a recent report by Fortune Business insights™ titled, “Cardiovascular Devices Market, 2021-2028.” According to the report, the market size was USD 50.87 billion in 2020.
Key Industry Developments Include:
June 2021: Cardiovascular Systems, Inc. introduced OrbusNeich JADE percutaneous transluminal angioplasty (PTA) over-the-wire balloon catheters.
Request a Sample Copy of the Research Report:
Market Segments:
Based on device type, the market is segmented into diagnostic and monitoring devices and therapeutic and surgical devices. The diagnostic and monitoring devices segment can be further sub-segmented into electrocardiogram (ECG), remote cardiac monitoring, and others. The therapeutic and surgical devices segment can be further sub-segmented into ventricular assist devices (VAD), cardiac rhythm management (CRM) devices, catheters, stents, heart valves, and others. By application, the global market for these devices is categorized into coronary artery disease (CAD), cardiac arrhythmia, heart failure, and others. Based on end-user, the global market is classified into hospitals, specialty clinics, and others. Geographically, the global market is widespread into the regions of North America, Europe, Asia Pacific, Latin America, and the Middle East, and Africa.
COVID-19 Pandemic:
COVID-19 has had a detrimental influence on the cardiovascular devices industry due to the worldwide postponement of elective cardiovascular operations since hospital visits have decreased. While few procedures are considered urgent because of the ongoing COVID-19 epidemic, several have been rescheduled. Percutaneous coronary intervention (PCI) for an…
Read More: Cardiovascular Devices Market Size | Is Prognosticated to Reach USD